PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 25, Pages E5766-E5775
Publisher
Proceedings of the National Academy of Sciences
Online
2018-06-05
DOI
10.1073/pnas.1804779115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation
- (2017) Marc A.J. Morgan et al. GENES & DEVELOPMENT
- PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1
- (2017) Xiang Jiao et al. Oncotarget
- Regulation of Replication Fork Advance and Stability by Nucleosome Assembly
- (2017) Felix Prado et al. Genes
- A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
- (2016) Oakley B. Cox et al. Chemical Science
- A replicator-specific binding protein essential for site-specific initiation of DNA replication in mammalian cells
- (2016) Ya Zhang et al. Nature Communications
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromatin proteomic profiling reveals novel proteins associated with histone-marked genomic regions
- (2015) Xiong Ji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PHIPing Out: A Genetic Basis for Tumor Ulceration
- (2014) Jack L. Arbiser JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration
- (2013) Vladimir Bezrookove et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells
- (2013) Shashi Rajput et al. LIFE SCIENCES
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients
- (2012) Mary Anne Quintayo et al. BREAST CANCER RESEARCH AND TREATMENT
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- The bromodomain interaction module
- (2012) Panagis Filippakopoulos et al. FEBS LETTERS
- Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
- (2012) Lewis R. Vidler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis
- (2012) D. De Semir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromatin assembly controls replication fork stability
- (2009) Marta Clemente-Ruiz et al. EMBO REPORTS
- Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells
- (2009) Junichi Soh et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started